Buchumschlag

Ledipasvir plus sofosbuvir fixed-dose combination for 6 weeks in patients with acute hepatitis C virus genotype 1 monoinfection (HepNet Acute HCV IV): an open-label, single-arm, phase 2 study

Background Early treatment of acute hepatitis C virus (HCV) infection with interferon alfa is highly effective, but can be associated with frequent side-effects. We investigated the safety and efficacy of an interferon-free regimen for treatment of acute HCV infection.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Deterding, Katja (VerfasserIn) , Pathil-Warth, Anita (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2017
In: The lancet. Infectious diseases
Year: 2016, Jahrgang: 17, Heft: 2, Pages: 215-222
ISSN:1474-4457
DOI:10.1016/S1473-3099(16)30408-X
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1016/S1473-3099(16)30408-X
Verlag, Volltext: https://linkinghub.elsevier.com/retrieve/pii/S147330991630408X
Volltext
Verfasserangaben:Katja Deterding, Christoph D Spinner, Eckart Schott, Tania M Welzel, Guido Gerken, Hartwig Klinker, Ulrich Spengler, Johannes Wiegand, Julian Schulze zur Wiesch, Anita Pathil, Markus Cornberg, Andreas Umgelter, Caroline Zöllner, Stefan Zeuzem, Armin Papkalla, Kristina Weber, Svenja Hardtke, Heiko von der Leyen, Armin Koch, Dorothee von Witzendorff, Michael P Manns, Heiner Wedemeyer
Beschreibung
Zusammenfassung:Background Early treatment of acute hepatitis C virus (HCV) infection with interferon alfa is highly effective, but can be associated with frequent side-effects. We investigated the safety and efficacy of an interferon-free regimen for treatment of acute HCV infection.
Beschreibung:Available online 28 October 2016
Gesehen am 19.10.2018
Beschreibung:Online Resource
ISSN:1474-4457
DOI:10.1016/S1473-3099(16)30408-X

Ähnliche Einträge